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 Periodontitis is a chronic inflammatory disease initiated by gram negative anaerobic 
bacteria. These bacteria possess pathogen-associated molecular patterns (PAMPs) that 
interact with various receptors including Toll like receptors (TLRs). Bacterial DNA 
(bDNA) is one of the PAMPs mainly recognized by TLR9.  Interaction of bDNA and its 
receptors leads to activation of inflammatory signaling pathways potentially resulting in 
periodontal bone destruction. The aim of this study was to determine the production of IL-
6 and IL-8 in response to periodontal bDNA from human osteoblastic cells (MG-63). MG-
63 cells were stimulated in duplicate for 20 hours with 100ng/µl of bDNA from various 
pathogens including Porhyromonas gingivalis, Esherichia coli, Streptococcus sanguinis, 
Aggregatibacter actinomycetemcomitans as well as heat killed whole bacteria (1:100).  
 xiii
E.coli LPS (10ng/µl) was used as a positive control in each experiment. To block TLR9 
signaling, further experiments were carried out by treating MG-63 cells with chloroquine 
(10ng/µl) for 2 hours at 37ºC prior to stimulations. Cytokine levels were determined using 
enzyme linked-immunosorbent assay. Although IL-6 and IL-8 production was increased in 
response to periodontal bDNA in MG-63 cells, the results were not significant compared to 
unstimulated controls. As expected, E.coli DNA, E.coli LPS and heat killed whole bacteria 
stimulated significantly increased cytokine production (p<0.05). Blocking TLR9 with 
chloroquine did not affect the amount of cytokine production in bDNA stimulated cells 
suggesting that TLR9 may not be operant in triggering IL-6 and IL-8 production from MG-
63 cells. In conlusion, periodontal bDNA did not trigger significantly increased IL-6 and 
IL-8 production from MG-63 cells. Considering the involvement of several inflammatory 
mediators in periodontal bone destruction, further studies are warranted to assess the 
production of other cytokines in response to periodontal bDNA in human osteoblastic 
cells. 
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Introduction 
 
A. Pathogenesis of periodontal disease  
Periodontitis is an inflammatory disease of the periodontium characterized by a 
progressive destruction of the tissues supporting the tooth. Its primary etiology is a poorly 
characterized series of microbial infections including some of the 300 or more species of 
bacteria identified in the oral cavity (Darveau, Tanner et al. 1997). Oral health has been 
improving and new treatments and technologies are being implemented, but in spite of 
these advancements, periodontitis still affects a large number of adults and  a small number 
of children and teenagers worldwide (Y.-T.A.Teng 2005). Recent studies showed that 
periodontal disease not only leads to tooth loss, but also is a kind of early warning system 
associated with various systemic diseases such as diabetes (Southerland et al. 2005), 
kidney disease (Kshirsagar et al. 2005), preterm labor (Pretorius et al. 2007; Michalowicz 
and Durand 2007), osteoporosis, Alzheimer’s disease and certain types of cancer (Dietrich 
and Garcia 2005). 
 Periodontal diseases are initiated by a number of gram negative, anaerobic bacterial 
species which form dental plaque biofilms. These bacterial biofilms have been described as 
multispecies ecosystems where oral bacteria cooperatively interact with each other. 
Bacterial cells will either bind to the hard tissues including tooth and root surfaces and/or 
adhere to other bacteria that have already colonized on these surfaces, continuously 
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releasing cell surface components into the oral cavity and the gingival sulcus causing 
inflammation (Hojo, Nagaoka et al. 2009). In addition some of these bacterial species can 
invade soft tissues causing damage in deeper periodontal tissues. Up to now, no single 
bacterial species has been identified as the primary species responsible for periodontal 
disease. However it is widely accepted that gram negative, anaerobic bacteria such as 
Porphyromonas gingivalis, Treponema denticola, Tanerella forsythia and Aggregatibacter 
actinomycetemcomitans initiate periodontitis, and the unbalanced host immune response to 
these pathogenic stimuli is responsible for the periodontal tissue destruction.  
 Gram negative anaerobic bacterial cells have the ability to penetrate the gingival 
epithelium. As such, their virulence factors like lipopolysaccharide, lipids, proteins, 
endotoxin, immunologically active compounds and cytotoxic enzymes are presented 
directly to the host’s inflammatory cells (Darveau, Tanner et al. 1997). Once bacterial 
invasion takes place, the periodontal epithelium is breached, leading to inflammation and 
the destruction of the connective tissue and eventually causing bone loss and possible tooth 
loss (Dale 2002). Figure 1 is a schematic diagram briefly summarizing the initial immune 
responses that take place in the periodontium. 
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Figure 1. Bacterial invasion of periodontal structures, and host immune response to this 
antigenic challenge (adapted from Dale 2002). 
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There is a dynamic equilibrium between dental plaque and the host immune 
response. Dental plaque bacteria have adapted survival strategies that favor growth in this 
environment, while the host limits growth by a combination of innate and adaptive 
immune responses (Darveau, Tanner et al. 1997). The host immune system will respond to 
invading pathogens by detecting conserved pathogen associated molecular patterns 
(PAMPs) through a variety of receptors called pattern recognition receptors (PRRs) that 
include Toll-like receptors (TLRs). A microbial PAMP binds to its TLR and transmits a 
signal to the host cell’s nucleus inducing the expression of genes coding for the synthesis 
of several mediators called cytokines and chemokines (M. Azuma, 2006). Chemokines, 
such as IL-8, are a family of small polypeptides and are supposed to act as potent 
chemoattractants enhancing inflammatory cell infiltration and thus contributing in bone 
destruction (Suva and Bendre 2005). They play an important role in the pathogenesis of 
periodontitis. Other cytokines such as IL-6, IL-1β and tumor necrosis alpha (TNF-α) 
undergo biological activities that are known to be involved in the progress of this disease. 
These activities include the activation of osteoblasts and fibroblasts (Yumoto, Nakae et al. 
1999). The disease progresses as periodic, i.e. relatively short episodes of rapid tissue 
destruction followed by some repair and then prolonged intervening periods of disease 
remission. But despite the apparent random distribution of episodes of disease activity, the 
tissue breakdown exhibits a symmetrical pattern of alveolar bone loss and pocket 
formation common to several forms of periodontitis. The distribution of the affected teeth 
and surfaces may vary among diseases. 
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B. Periodontal PAMPs and their role in periodontal disease 
  As mentioned before, bacteria and their cell wall components may initiate a host 
immune response, which includes innate and adaptive immunities. PAMPs trigger innate 
immunity in the early phase of infection through pattern recognition receptors (PRRs) such 
as the TLRs that are expressed on a number of cells including phagocytic cells, dendritic 
cells, endothelial cells, mucosal epithelial cells and lymphocytes (Akira, 2006; Akira et al. 
2006). Structurally, TLRs are single membrane non-catalytic receptors which comprise a 
family of type I transmembrane proteins and are characterized by an extracellular leucine-
rich repeat domain and an intracellular toll/interleukin-1 receptor (TIR) domain (M. 
Azuma, 2006; Kumagai, Takeuchi et al. 2007). There are at least 11 different types of 
TLRs; those recognizing structure components of pathogens such as proteins, lipoproteins, 
polysaccharides (TLR1, TLR2, TLR4, TLR5, TLR6, TLR10) are extracellular and those 
that are specialized to recognize polynucleotides such as RNA and DNA (TLR3, TLR7, 
TLR8, TLR9) are intracellular and meet their ligand in the endosomal compartment 
(Amcheslavsky et al. 2005; Azuma 2006) as depicted in Figure 2. 
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Figure 2. The different TLRs and their location within a cell (adapted from Takeda and 
Akira 2005).  
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Some of the PAMPs associated with periodontal pathogens include LPS, gingipains 
(specific to the bacterium P. gingivalis), bacterial fimbriae, BspA protein of T.forsythia 
and bacterial DNA (bDNA) (Darveau, Tanner et al. 1997; Madianos, Bobetsis et al. 2005; 
Tatakis and Kumar 2005; Uehara et al. 2008; Sahingur et al. 2010). These PAMPs each 
play important role in periodontal disease pathogenesis mainly by promoting production of 
inflammatory mediators. Among these PAMPs, bacterial DNA (bDNA), the focus of our 
study, is one of the newly emerging PAMPs that might be involved in inflammation-
induced tissue destruction associated with periodontal disease (Sahingur et al. 2010).  
Bacterial DNA (bDNA) is mainly recognized through TLR9 and bDNA-TLR9 
interactions have been involved in inflammation-induced tissue destruction in several 
diseases such as sepsis (Plitas et al., 2008; Sjolinder et al., 2008), systemic lupus 
erythematosus (Komatsuda et al., 2008; Wu et al., 2009; Zorro et al., 2009), and 
rheumatoid arthritis (Loos et al., 2006, Nakano et al., 2008; Rudnika et al., 2009), most of 
which share a common pathophysiology with periodontal disease. The studies conducted 
in our laboratory (Sahingur et al. 2010) as well as by other investigators point out a 
possible involvement of bDNA-initiated and TLR9 mediated inflammatory responses in 
periodontal pathology (Takeshita et al. 1999; Nonnenmacher et al.2003). The next section 
will briefly summarize the interaction of bDNA with host immune cells and the evidence 
linking bDNA- initiated immune responses in periodontal disease.  
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C. Interaction of bacterial DNA (bDNA) with TLR9 and their role in 
periodontal disease 
Microbial DNA sequences containing unmethylated CpG (Cytosine-phosphate-Guanosine) 
dinucleotides mainly activate Toll-like receptor 9 (TLR9) leading to the production of pro-
inflammatory cytokines as shown in figure 3 below (Ewaschuk, Backer et al. 2007; 
Kumagai, Takeuchi et al. 2007).  Recent studies also implicated other receptors, such as 
AIM-2 (Absent In Melanoma-2) and DAI (DNA–dependent Activator of Interferon-
regulatory factors) in foreign DNA recognition (Takaoke et al. 2007; Muruve et al. 2008; 
Hornung et al. 2009). The stimulatory effect of bDNA is conferred by unmethylated CpG 
dinucleotides in particular base contexts (CpG motifs) that also determine the species-
specific activity of the nucleic acids. Accumulating evidence suggests that bDNA and 
TLR9 interact in intracellular compartments. As bDNA is internalized through 
endocytosis, TLR9 relocates. The accumulation of bDNA and TLR9 in the endosomes 
leads to their co-localization within the same vesicles, and induces the recruitment of 
MyD88 to initiate signaling (Takeshita F. et al. 2004; Kumagai, Takeuchi et al. 2007). 
TLR9 recognizes specifically bDNA that is unmethylated and single stranded (ss). 
Methylation of the cytosine within the CpG motif strongly reduces the affinity of TLR9 
(Rutz M et al. 2004). Due to the abundance of unmethylated/hypomethylated cytosine-
phosphate-guanosine (CpG) dinucleotides (CpG motifs) in the bacterial genome (Bauer et 
al, 2001), host cells have been shown to distinguish pathogenic DNA from host DNA.  
These motifs are found to be mostly methylated and rare in eukaryotic DNA (Ewaschuk, 
Backer et al. 2007; Kumagai, Takeuchi et al. 2007).  
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The majority of the studies thus far have used synthetic CpG oligonucleotides to 
investigate the receptor-ligand interactions in bDNA-mediated immune responses (Dalpke 
et al. 2002; Kreig, 2006; Heeg et al. 2008). Varying from synthetic CpG oligonucleotides, 
the structures of naturally-occurring TLR9 activators such as bacterial genomic DNA are 
more heterogeneous. Moreover, besides differences encountered between native DNA and 
oligonucleotides, the extent of the immune response to different bacterial nucleic acids 
may show differences depending on cell type (Dalpke et al. 2006; Mogensen et al. 2006). 
Thus, it remains important to ascertain the immunostimulatory effect of native bDNA from 
different pathogens in various cell types to assess the contribution of these molecular 
structures to the pathologic processes. Previous studies investigated periodontal bacterial 
DNA triggering cytokine (IL-6 & TNF-α) release from human gingival fibroblasts and 
murine macrophages (Takeshita et al.1999; Nonnenmacher et al. 2003). Moreover, the 
expression of TLR9 is increased in periodontally diseased tissues compared with healthy 
sites supporting a possible role of TLR9 and its ligand in periodontitis (Kajita et al. 2007; 
Beklen et al. 2008). Most recently, studies in our laboratory demonstrated increased pro-
inflammatory cytokine production from human monocytes (THP-1) in response to various 
periodontal pathogenic DNA via TLR9 and NF-kappa B (NF-KB) signaling pathway 
(Sahingur et al. 2010). Considering differential responses to bDNA in various cells, this 
study is designed to investigate the possible effect of periodontal bDNA on human 
osteoblastic cells.  
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Figure 3. Structure of Toll-like receptors and their signaling pathway (adapted from 
Azuma 2006) 
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D. The role of the osteoblast-osteoclast balance in periodontal disease  
As mentioned before, periodontitis is characterized by periodontal pocket formation 
and alveolar bone resorption eventually leading to tooth loss. That occurs due to the 
impairment of the normal bone remodeling via unbalanced inflammatory responses. Bone 
remodeling is regulated by the balance between osteoclast and osteoblast formation and 
activity, known as alveolar bone homeostasis (Mori, Brunetti et al. 2007).  
Osteoblast’s function is to synthesize the organic matrix components and to direct the 
events resulting in mineralization. The osteoblast becomes an osteocyte once it is 
surrounded with the mineralized matrix and these osteocytes which are known to maintain 
the mineralized matrix, work cooperatively with osteoblasts to produce proteases that are 
involved in degrading and remodeling the extracellular matrix resulting in its maturation 
and calcification. In addition, osteoblasts are involved in the production of paracrine and 
autocrine factors such as cytokines and growth factors which deeply influence both the 
formation and resorption of bone. In contrast, osteoclasts, cells of hematopoietic origin, 
function in the resorption of the mineral and organic phases of the bone ultimately working 
in concert with osteoblasts and osteocytes to remodel and maintain skeletal integrity 
throughout life (Schwartz et al. 1997; Spyrou et al. 2001; Stanley et al. 2006). In short, a 
balance between the activities of both osteoblasts and osteoclasts determine the level of 
bone mass.  
Receptor activator of nuclear factor-kB ligand (RANKL) and its decoy receptor, 
osteoprotegerin (OPG) are essential molecules for the differentiation of osteoclasts 
regulated by osteoblasts. Other resident cells besides osteoblasts such as periodontal 
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ligament fibroblasts and gingival fibroblasts also regulate RANKL and osteoprotegerin 
behavior in periodontal tissues (Nagasawa, Kiji et al. 2007). Preosteoblastic cells and 
stromal cells express RANKL, which binds to its receptor RANK on the surface of 
osteoclasts and their precursors as shown in figure 4. 
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Figure 4. Preosteoblastic/stromal cells regulation of osteoclastogenesis (adapted from 
Khosla 2001). 
 
 
 
 
 
 
 14
Macrophage colony stimulating factor (M-CSF) which binds to its receptor c-Fms on 
preosteoclastic cells is essential for the development of osteoclasts because it is the 
primary determinant of the pool of these precursor cells. RANKL, however, is critical for 
the differentiation, fusion into multinucleated cells, activation and survival of osteoclastic 
cells. OPG is secreted by osteoblasts and osteogenic stromal stem cells and protects the 
skeleton from excessive bone resorption by binding to RANKL preventing it from 
interacting with RANK and blocking its effectiveness (Khosla 2001; Boyce and Xing, 
2007). A number of proresorptive cytokines and chemokines such as IL-6 and IL-8 
modulate this system primarily by stimulating M-CSF production thereby increasing the 
pool of preosteoclastic cells and by directly increasing RANKL expression. Furthermore a 
number of other cytokines (TNF-α and IL-1β) and hormones exert their effects on 
osteoclastogenesis by regulating the RANKL/OPG system (Schwartz et al. 1997). While 
our main focus is on both IL-6 and IL-8, other cytokines/chemokines will be further looked 
at in future studies.  
 IL-6 is known to modulate the differentiation of osteoblasts and osteoclasts 
(Marriott et al. 2008). It is believed to play a positive regulatory role in osteoclast 
differentiation by inducing the expression of RANKL on the surface of osteoblasts 
(Marriot et al. 2008). It has been demonstrated in recent studies that IL-6 can also directly 
act on osteoclast progenitors to suppress their differentiation via an inhibition of RANK 
signaling pathways as shown in  figure 5 (Yoshitaki et al. 2003). 
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Figure 5. Effect of IL-6 on osteoclastogenesis (adapted from Yoshitaki et al. 2008) 
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IL-8 expression is elevated during a number of inflammatory processes including 
periodontal disease which is associated with osteoclast activation and bone destruction 
(Suva and Manali 2005). IL-8 is able to regulate the expression of the essential 
osteoclastogenic factor (RANKL), by osteoblastic stromal cells, and can also up-regulate 
parathyroid hormone (PTH) production by cells of the parathyroid gland. Regulation of 
parathyroid hormone, a hormone involved in the normal calcium metabolism coupled with 
the production of IL-8 by a variety of different cell types in bone suggests that IL-8 may be 
an important mediator in bone homeostasis (Suva and Manali 2005). 
 Recent studies have shown that not all regulation of the osteoclast is exclusively via 
the osteoblast because calcitonin acts directly on osteoclastic cells, and estrogen has been 
shown to induce apoptosis of osteoclasts as well as inhibit osteoclast differentiation by 
interfering with RANK signaling (Yoshitaki et al. 2003). Moreover, RANK expression can 
also be stimulated by TGF-β on preosteoclastic cells enhancing osteoclastic sensitivity to 
RANKL. The RANKL/OPG ratio in bone marrow is thus an important determinant of 
bone mass in normal and disease state (Khosla 2001). 
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E. Periodontal microbiology and the microorganisms used in this study  
The supragingival biofilm of healthy gingivae is composed of a few (1-20) layers of 
oral streptococci, gram positive rods, and a few gram negative cocci. However, dental 
plaque associated with clinical gingivitis is composed of 100-300 layers, predominantly 
anaerobic gram-negative rods and filaments. Depending on environmental characteristics, 
the species found in bacterial biofilms can vary but patterns of colonization are fairly stable 
(Stingu, Eschrich et al. 2008). Streptococcus sanguinis, is a gram positive facultative 
coccus species of bacteria.  It is a normal inhabitant of the healthy human mouth where it is 
found in dental plaque. It modifies the environment to make it less hospitable for other 
strains of streptococcus that cause cavities, such as streptococcus mutans. S.sanguinis may 
enter the blood stream when the opportunity presents itself. Once there, it can colonize the 
heart valves. It is the most common cause of subacute bacterial endocarditis (Li et al. 
2003). S.sanguinis strain ATCC 10556 was selected as a non-pathogenic oral bacterial 
control in this study.  
P.gingivalis w83 was chosen because it is known to be a virulent strain. It is a gram 
negative rod associated with severe and chronic periodontal diseases (Tachibana-ono, 
Yoshida et al. 2007). Progression of the disease is caused by the colonization of this 
organism in an anaerobic environment in host tissues and severe progression can 
eventually lead to tooth loss. The black pigmentation of this bacterium comes from iron 
acquisition that does not use the typical siderophore system of other bacteria that 
accumulate hemin (Tachibana-ono et al. 2008; Lin, Li et al. 2009). Peptides appear to be 
the predominant carbon and energy source of this organism, perhaps in keeping with its 
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ability to destroy host tissue. Oxygen tolerance systems play a part in establishing the 
organism in the oral cavity, including a superoxide dismutase (Najjar 2008). Pathogenic 
factors include extracellular adhesins that mediate interactions with other bacteria as well 
as the extracellular matrix, and a host of degradative enzymes that are responsible for 
tissue degradation and the spread of the organism including the gingipains, which are 
trypsin-like cysteine proteases. Proteinases attack extracellular matrix proteins, cell 
adhesion molecules, and immune system proteins such as cytokines and gamma interferon 
(Andrian, Grenier et al. 2006).  
 Aggregatibacter actinomycetemcomitans, previously Actinobacillus 
actinomycetemcomitans, is a gram negative facultative non-motile rod found in severe 
infections in the oral cavity, mainly the periodontium. It possesses certain virulence factors 
that enable it to invade tissues such as leukotoxin (Shimada, Nishihara et al. 2008; 
Kachlany, 2010). Leukotoxin has destructive effect on neutrophiles, monocytes, and T-
lymphocytes, and in that way leads to the local immunosuppression in supragingival area 
which has a central role in development of periodontal lesions in juvenile periodontitis. 
This is why leukotoxin from A. actinomycetemcomitans is an essential virulent factor, and 
this microorganism has been used in our study since it is an important periodontal 
pathogen (Kachlany, 2010).  
 Esherichia coli is a gram-negative rod shaped bacterium that is commonly found in 
the lower intestine of warm blooded organisms (Todar 2004). The non-oral microorganism 
E. coli served as a source of ubiquitous, non-periodontal disease-associated antigens. 
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F. Study objective  
The cellular and molecular events related to bone cells constitute the end stage of 
periodontal disease. Hence, a better understanding of the interaction of bDNA with 
osteoclasts and osteoblasts might potentially lead to new therapies to treat bone disease, 
including periodontal disease. Bacterial DNA is one of the newly emerging pathogen-
associated molecular patterns (PAMPs) that might be involved in inflammation-induced 
tissue destruction associated with periodontal disease. Therefore, in this study, we seek to 
determine pro-inflammatory cytokine production, specifically cytokines/chemokines IL-6 
and IL-8 in response to periodontal bacterial DNA in the osteoblastic cell line MG-63, and 
compare that with responses generated from whole bacterial cells. 
Most of the previous studies have employed CpG oligodeoxynucleotides (CpG-
ODNs) that are known to mimic bacterial DNA to elucidate the role of DNA recognition 
by osteoblastic and osteoclastic cells (Zou et al. 2003; Amcheslavsky et al. 2004; 
Amcheslavsky et al. 2005); however, in our study whole genomic bacterial DNA was 
isolated from different types of bacteria and used in the stimulation of the osteoblastic cell 
line MG-63. In this study, we also characterize the interactions of bDNA with osteoblasts 
in comparison with LPS as well as whole bacteria. 
Varying from synthetic CpG oligonucleotides, the structures of naturally-occurring 
TLR9 activators are more heterogeneous. Hence, it is sometimes hard to predict the effects 
of bacterial nucleic acid initiated immune responses by extrapolating results obtained with 
synthetic oligonucleotides. Because of this, it remains important to ascertain the 
immunostimulatory effect of native bDNA from different pathogens in various cell types 
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to assess the contribution of these molecular structures to the pathologic processes of 
periodontal diseases. This will be the first study that will determine the effect of 
periodontal bDNA in osteoblastic cells. 
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Materials and Methods 
 
 
 
A. Morphology and Characteristics of MG-63 cells 
 
 
 
 
 
 
 
 
 
 
Figure 6. Microscopic view of the MG-63 cell’s morphology  
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Table 1. Characteristics of the MG-63 cell line 
 
 
Cell line designation MG-63 
ATCC catalog # CRL-1427 
Organism Homo sapiens 
Organ Bone 
Disease Osteosarcoma 
Morphology Fibroblast 
Growth properties Adherent 
cellular products Interferon 
 
 
 
 
 
 
 23
B. MG-63 Cell culture 
The base medium for this cell line is ATCC-formulated Eagle’s Minimum Essential 
Medium, catalog # 30-2003. To make the complete growth medium, heat-inactivated fetal 
bovine serum (FBS) (Gibco, Invitrogen) was supplemented to a final concentration of 10% 
and 1% Penicillin-Streptomycin (Gibco, Invitrogen) was added. In order to make FBS 
heat-inactivated, fetal bovine serum (not heat activated) was put in a water bath for 30 min 
at a temperature of 56°C. 
             The main cell line that was used in this research project was MG-63. These cells 
were originally isolated from a human osteosarcoma (Billiau et al., 1975) and purchased 
from ATCC catalog # CRL-1427 (Manassas, VA). The cell vial was removed from storage 
at    -140°C and thawed by gentle agitation in a 37°C water bath. Both the O-ring and cap 
were kept out of the water to reduce contamination. The vial was then removed from the 
water bath as soon as the content was thawed and decontaminated by spraying 70% 
ethanol. The vial content was transferred to a centrifuge tube containing 9.0 ml complete 
culture medium and centrifuged approximately 125 x g for 7 minutes. The cell pellet was 
re-suspended with the recommended complete medium and dispensed into a 75 cm2 flask 
(Corning CellBind Surface). The cells were maintained at 37°C in a fully humidified 
atmosphere at 5% CO2 in air. 
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C. MG-63 Cell passaging 
The culture medium was removed and discarded from the flask containing the cells. 
The cell layer was briefly rinsed with 0.25% (w/v) Trypsin-0.53mM EDTA (Gibco) 
solution to remove all traces of serum which contains trypsin inhibitor. 3.0 ml of Trypsin-
EDTA solution was added to the flask which was then placed at 37°C for 5 to 10 minutes 
allowing the cells to detach. The cells were observed under an inverted microscope making 
sure the cell layer has dispersed. 6.0 to 8.0 ml of complete growth medium was added and 
the cells were aspirated by gently pipetting. Appropriate aliquots of the cell suspension 
were added to new culture vessels with a subcultivation ratio of 1:4 to 1:8. New cultures 
were incubated at 37°C.The media was changed every 48 hours and the cells were 
passaged with trypsin-EDTA every 3 days. 
 
D. MG-63 Cell storage 
The culture medium was removed from four flasks and discarded. The cell layer from 
each flask was briefly rinsed with 0.25% trypsin, 0.03% EDTA solution to remove all 
traces of serum which contained trypsin inhibitor. An additional 2 to 3 ml of trypsin-EDTA 
solution was added to each flask. The flasks were allowed to sit in the incubator at 37°C 
for 5 to 10 min until the cells detach. 10 ml of fresh culture medium was then added to 
each flask, transferred into a 50 ml centrifuge tube and centrifuged at 800 x rpm for 7 min. 
The cells were counted (freeze about 2x106cells/ml. At least 1x106 cells and up to 5.4x106 
cells). Media was added to the cells to make the concentration around 2x106cells/ml and 
mixed well. DMSO (BP231-100, Fisher BioReagents) was added to the cell suspension 
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until it reached 5%. 1.5 ml of cell suspension (with 5% DMSO) was added into a 2 ml vial 
and put on ice immediately. The vials were transferred to the -80°C freezer then transferred 
to the -140°C freezer the next day. 
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E. Bacterial cell culture conditions  
 
 
 
 
 
Table 2. List of bDNA and LPS used to stimulate osteoblasts 
 
 
bDNA & LPS Description Reference  
Ec Strain DH-10B 
Dr. Kitten's lab, VCU, 
Richmond, VA 
Pg Strain W83 
Dr. Schenkein's lab  
VCU, Richmond VA 
Aa Strain D045-D40 
Dr. Schenkein's lab 
VCU, Richmond, VA 
Ss Strain 10556 
Dr. Schenkein's lab VCU, 
Richmond, VA 
Pg LPS Strain 184 
Dr. Shifferle’s lab.  
UB, Buffalo, NY  
Pg LPS Strain 381 
Dr. Shifferle’s lab.  
UB, Buffalo, NY   
Ec LPS EH100  
SIGMA 
St. Louis, MO 
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All of the bacteria (P.gingivalis, S.sanguinis, A.actinomycetemcomitans)) except 
E.coli were grown in brain heart infusion broth (Difco Laboratories, Detroit, Mich.) 
supplemented with 0.5% yeast extract (Difco Laboratories), hemin (5µg/ml), vitamin K 
(0.5µg/ml), and cysteine (0.1%) (Sigma-Aldrich, St. Louis, Mo.). All cultures were 
incubated at 37°C in an anaerobic chamber (Coy Manufacturing, Ann Arbor, Mich.) in 
10% H2, 10% CO2, and 80% N2.   
 The E.Coli medium was made of 10g  Difco LB Broth ref #  240230 (Becton, 
Dickenson and Company) added into 500ml autoclaved water. One vial of E.coli was taken 
from the -80°C freezer, thawed, seeded into a 50ml LB broth medium, then incubated at 
37°C in the shaking incubator overnight (16 hours) at a speed of 250 rpm. 
 
 
 
 
 
 
 
 
 
 
 
 28
 
F. Bacterial DNA (bDNA) isolation 
 
 
 
Table 3. Reagents used in the isolation of bDNA 
 
 
1) RNase, lysozyme and proteinase were added to 
digest the proteins making it easier for the extraction 
of bDNA 
2) Phenol: chloroform: isoamyl alcohol (25:24:1) 
3) Chloroform 
4) 3M Sodium Acetate (pH 5.0) prepared by adding 
glacial acetic acid to 3M Sodium acetate until this 
pH is obtained. 
12.3 grams of Sodium acetate was added into 50 ml 
of sterile water (pH 5.0), autoclaved and stored at 
4°C 
5) Ice cold 100% ethanol 
6) 70% ethanol 
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Bacterial cells were grown overnight in 500 ml of broth medium and the pellet cells 
were collected by centrifugation and re-suspended in 10 ml 50mM Tris at a pH of 8.0, and 
50 mM EDTA. The cell suspension was placed in the freezer at -20°C. One day later, 0.2 
ml of 50 mg/ml lysozyme was added to the frozen suspension and let thaw at room 
temperature. Once thawed, the cell suspension was placed on ice for 45 minutes. Also, 2ml 
of 2.0% SDS, 10 mM Tris (pH 7.5), 10 M EDTA and 0.25 ml of 10 mg/ml of proteinase K 
were added to the cell suspension, and placed in a 50°C water bath for 60 minutes; 400µl 
(30 tube X2) of the bacterial lysis mixture were extracted with equal volume of 
phenol:chloroform:isoamyl alcohol, mixed by vortex for 10 seconds and centrifuged at 
10,000X g for 15 minutes. The top layer was transferred to a new tube (avoiding interface) 
and an equal volume of chloroform was added and mixed by vortex for 10 seconds and 
centrifuged at 10,000X g for 15 minutes. Again, the top layer was transferred to a new tube 
(avoiding interface) and 0.1 volume  of 3M Na acetate was added and mixed gently, then 2 
volume of 95% ethanol was added, which was mixed by inverting; the DNA was spooled 
out and transferred to 4 ml of autoclaved water, and was dissolved by vortex. After 
bacterial DNA was extracted and purified, polymyxin-B solution EC # 2157747 (Sigma-
Aldrich) was added for further purification. 100µl of polymyxin-B was added for every 
300µl DNA and set for 30 min to allow the complete binding of LPS to polymyxin-B. 
DNA was transferred to a new tube and re-precipitated. The purity and concentration of the 
DNA was determined by using spectrophotometric analysis (Nanodrop model # ND-1000 
spectrophotometer) and by undergoing gel electrophoresis. The amount of LPS was 
measured by the Limulus Amoebocyte Lysate assay (LAL) described below. 
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G. Gel electrophoresis 
 
Reagents used in gel electrophoresis included; 1xTBE (prepared from 10xTBE), 0.5 
grams of agarose and ethidium bromide. 
 
 Gel electrophoresis technique: 
 
 50 ml of 1xTBE (catalog # B52, Fermentas life science) were put in a sterile beaker 
and 0.5g agarose (catalog # 162-0022, Bio-Rad laboratories) were added. The mixture was 
heated in the microwave and 2µl of Ethidium Bromide (CAS 1239-45-8, OmniPur) was 
added. The gel was then poured into the gel casting tray and was allowed to set for at least 
45 min. Once the gel has set, the combs and casting gates were removed, the gel was 
transferred to the gel tank and 1xTBE solution was poured into the gel tank until the gel 
was completely covered. Different DNA samples were mixed with dye and loaded into the 
wells in the gel (3µl DNA + 5µl dye +5µl H2O). The ladder was also loaded and the gel 
was run at 100 volts for 45 min. The gel was photographed under ultraviolet light. 
 
H. Limulus Amoebocyte Lysate (LAL) assay  
Limulus Amoebocyte Lysate (LAL) QCL-1000 catalog number: 50-647U was 
purchased from Lonza (Walkerville, MD USA) and the amount of LPS in the bacterial 
DNA samples was determined in all the DNA samples according to the manufacturer’s 
instructions. The chromagenic substrate was reconstituted with 6.5ml LAL water and kept 
in 4°C. The following 4 standards of endotoxin were made as shown in table 4. 
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Table 4. LAL assay; Endotoxin standards preparation  
 
Standards Concentration Preparation 
Standard #1 1.0 EU/ml 1.4ml LAL water was added to 0.05ml original 
stock endotoxin solution and vortexed well 
Standard #2 0.5 EU/ml 0.2ml of standard #1 was added to 0.2ml LAL 
water and vortexed well 
Standard #3 0.25 EU/ml 0.2ml of standard #1 was  added to 0.6ml LAL 
water and vortexed well 
Standard #4 0.1EU/ml 0.1ml of standard #1 was added to 0.9ml LAL 
water and vortexed well 
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The microplate was pre-equilibrated at 37°C. 50µl of standards and samples were 
added to the appropriate wells. 50µl of water was added to the two blanks. 50µl of LAL 
was added to the wells at the same time. The plate was tapped briefly and incubated at 
37°C for 10 minutes. 100µl of substrate was then added to the wells, the plate was briefly 
tapped again and incubated at 37°C for 6 minutes. 100µl of stop reagent (25% glacial 
acetic acid) was added to each well and the absorbance was read at 405-410 nm using the 
original multiscan MCC manufactured for Fisher Scientific (reference # 5111340). 
 
I. Determination of optimum time for osteoblasts (MG-63 cells) to release cytokines in 
response to bDNA. 
MG-63 cells were plated at a concentration of 4x105cells/well in a 48 well plate and 
incubated overnight under an atmosphere of 5% CO2 at 37°C. Cells were infected with 
100ng/µl P.gingivalis DNA in duplicates as well as E.coli DNA (100ng/µl), S.sangunis 
DNA (100ng/µl), A. actinomycetemcomitan DNA (100ng/µl), E.coli LPS(10ng/µl), 
P.gingivalis LPS 381 (10ng/µl ), P.gingivalis LPS 184(10ng/µl ), however un-stimulated 
cells were used as a control. Cells were incubated with bacterial DNA and LPS for 1 hour, 
2 hour, 4 hour, 8 hour, 12hour and 24 hour time points at 37°C in 5% CO2. Supernatants 
were collected and frozen to further determine IL-6 and IL-8 release by Enzyme-linked 
immunosorbent assay (ELISA). 
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J. Determination of optimum bDNA concentration for osteoblasts (MG-63 cells) to 
release cytokines in response to bDNA. 
MG-63 cells were plated at a concentration of 4x105cells/well in a 48 well plate and 
incubated overnight under an atmosphere of 5% CO2 at 37°C. Cells were infected at 
different concentrations (100ng/µl, 200ng/µl and 400ng/µl) in duplicates with P.gingivalis 
DNA, E.coli DNA, Ss DNA, Aa DNA. They were also infected with E.coli LPS at 
different concentrations (10ng/ µl, 25 ng/ µl, 50 ng/ µl) and un-stimulated cells were used 
as a control. Cells were incubated for 24 hours at 37°C in 5% CO2. Supernatants were 
collected and frozen to further determine IL-6 and IL-8 release by Enzyme-linked 
immunosorbent assay (ELISA). 
 
K. Stimulation of MG-63 cells by bDNA and heat killed whole bacteria 
Bacterial DNA was diluted with a proportional amount of autoclaved water, boiled 
for 5 minutes then put on ice for 1min. An additional amount of polymyxin-B (25%) was 
added to the DNA to eliminate any remaining LPS traces.  All the stimulators were 
incubated for 30min at 37°C. Bacterial DNA (100ng/µl) and LPS (10 ng/µl) were added to 
the MG-63 and cells were incubated for 20 hours.  For cell stimulations involving whole 
bacterial cells, bacteria were heat-killed and added to the MG-63 cells at a multiplicity of 
infection (MOI) of 100:1 (bacteria to cell ratio). This ratio indicates that this amount of 
bacteria is sufficient for osteoblasts activation without damaging the host cell.  Prior to 
stimulating the osteoblastic cell line, bacteria were harvested at an OD660 of 0.9. 1ml of 
bacteria culture suspension was taken and centrifuged at 12,000xg for 10 minutes. The 
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supernatant was discarded while the bacterial pellet was resuspended in OD660/2 ml of cell 
culture medium then put in a water bath for 15 min at a temperature of 80°C in order to kill 
the bacteria. The appropriate number of bacteria (1x109) was added to the MG-63 cells and 
incubated at 37°C in an atmosphere of 5% CO2. The supernatant was collected after 20 
hours and frozen for further study.  
 
L. Determination of the amount of IL-6 and IL-8 released from MG-63 cells by 
Enzyme-linked immunosorbent assay (ELISA). 
Human IL-6 enzyme linked immunosorbent assay (ELISA) Kit catalog # 88-7966-29 
was purchased from e.bioscience (San Diego, CA). This ELISA reagent set is specifically 
engineered for accurate and precise measurements of human IL-6 protein levels from cell 
cultures’ supernatants.  
5x assay diluent was diluted to 1x assay diluent. Standards and reagents were made 
according to the manufacturer’s instruction manual.  
Human IL-8 enzyme linked immunosorbent assay (ELISA) Kit catalog # 88-7087-22 
was purchased from e.bioscience (San Diego, CA). This ELISA reagent set is specifically 
engineered for accurate and precise measurements of human IL-8 protein levels from cell 
cultures’ supernatants.  
5x assay diluent was diluted to 1x assay diluent. Standards and reagents were made 
according to the manufacturer’s instruction manual.  
The ELISA assay was conducted as follows: 100µl of standards and samples (2µl 
sample + 98µl diluent) were added to the wells according to the experiment’s layout. The 
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plate was covered with a plate sealer, mixed gently and incubated at room temperature for 
2 hours. Each well was aspirated by 300µl of was buffer; this step was repeated for another 
4 times with 1 min interval. 100µl of detection antibody was added to each well; the plate 
was sealed and incubated for another hour. The wells were aspirated again and washed 
with another 300µl of wash buffer; this step was also repeated for another 4 time with 1 
min interval.100µl of Avidin-HRP diluent solution was added to each well, the plate was 
sealed and incubated for another 30 min. The wells were aspirated and washed with 300µl 
of wash buffer; this step was repeated for another 6 times with 2 min interval. 100µl of 
substrate solution was added to each well and the plate was sealed and incubated for 15 
min. 50µl of stop solution was added to each well and the plate was read at 450nm within 
30 min using the original multiscan MCC manufactured for Fisher Scientific (reference # 
5111340). 
 
M. Statistical analysis  
Cytokine levels were determined in supernatants using ELISA (R&D Systems). Data 
were analyzed by analysis of variance, using the Tukey and Dunn method with GraphPad 
Prism (version 4.0) software and the results were presented as the mean ± - SEM. The 
results represent at least five independent experiments which were run in duplicate. A 
value of P≤ 0.05 was considered significant. 
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Results 
A. Bacterial DNA purification and Limulus Amoebocyte Lysate (LAL) assay  
Whole bacterial genomic DNA was isolated by repeated phenol/chloroform 
extraction and ethanol precipitation as described previously to ensure pure DNA 
preparations. However, it is plausible to assume that bDNA isolated from gram negative 
bacteria would be contaminated with some LPS.  In order to further purify bacterial DNA, 
Polymyxin-B, a natural peptide, was used during DNA isolation to inactivate and remove 
any residual LPS. Polymyxin-B is a potent antibiotic that has the ability to bind and 
neutralize LPS. It is a decapeptide cyclic cationic antibiotic containing lipophilic and 
hydrophilic groups that binds to lipid-A, the major component of the endotoxin (Cardoso 
et al. 2007). By ensuring that the LPS is further neutralized via the polymyxin-B treatment, 
we can ensure that bDNA is stimulating the osteoblast not the LPS.  The 
lipopolysaccharide (LPS) concentration of all bacterial DNA preparations was determined 
using the Limulus Amoebocyte Lysate kit. Results were quantified using the graphical 
method protocol from the manufacturer’s handbook. The more polymyxin-B was added 
the less the amount of LPS found in bDNA as shown in table 5. 
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Figure7. LPS standard curve  
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        Table 5. Endotoxin levels after the addition of Polymyxin-B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          
 
 
 
 
 
 
 
Samples & Std OD ng/ml 
BLANK 0.364 0
S1 2.34 0.1
S2 1.458 0.05
S3 0.926 0.025
S4 0.577 0.001
Control 2.61 2.785
20µl 
polymyxinB+bDNA 0.853 0.0572
100 µl 
polymyxinB+bDNA 0.681 0.0356
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All of the samples were below 1EU/ml. 1 EU= 0.0001µg. Thus for the infection of 
MG-63 cells with 100µg/ml bacterial DNA, my samples contained 0.0356 ng/ml of LPS. 
Although the LPS concentration remained below stimulatory levels (<0.05 ng/ml) 
throughout the study, we still treated the bacterial DNA with polymyxin-B to further 
reduce the effect of LPS before stimulation of the cells. 
 
B. Bacterial DNA concentration and purity 
 
The quantity and the quality of the bacterial DNA preparations were assessed using 
two different methods: absorbance (optical density) by a spectrophotometer equipped with 
a UV light and agarose gel electrophoresis.  
 The spectrophotometric method involves performing absorbance readings at 260nm 
(A260) where DNA absorbs light most strongly. The number generated allows one to 
estimate the concentration of the solution and DNA purity can be estimated from the 
A260/A280 ratio. A260/A280: ratio of sample absorbance at 260 and 280 nm. A ratio between 
1.7 and 2.0 generally represents a high quality DNA sample.  If the ratio is appreciably 
lower, it may indicate the presence of protein, phenol or other contaminants that absorb 
strongly at or near 280nm. A260/A230: ratio of sample absorbance at 260 and 230nm. This is 
a secondary measure of nucleic acid purity. The 260/230 values for “pure” nucleic acid are 
often higher than the respective 260/280 values. They are commonly in the range of 1.8-
2.3. If the ratio is appreciably lower, this may indicate the presence of co-purified 
contaminants. In other words, DNA quality measurement is based on the fact that optical 
density (OD) at 260 nm is twice that at 280 nm if the solution contains pure DNA. In the 
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presence of a contaminant, there will be some additional OD which decreases the OD ratio 
between 260and 280 nm.  
The figures 8-11 below show the purity and concentration of each bacterial DNA used in 
this study after purification with Polymyxin-B. 
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Figure 8. Spectrophotometric analysis of the genomic DNA isolated from 
A.actinomycetemcomitans (Aa) bacteria 
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Figure 9. Spectrophotometric analysis of the genomic DNA isolated from P.gingivalis 
(Pg) bacteria 
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Figure 10. Spectrophotometric analysis of the genomic DNA isolated from E.coli (Ec) 
bacteria 
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Figure 11. Spectrophotometric analysis of the genomic DNA isolated from S. sanguinis 
(Ss) bacteria 
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C. Determination of the quality of bacterial DNA preparations using agarose gel 
electrophoresis  
Bacterial DNA preparations were further visualized using agarose gel electrophoresis 
that allowed us to determine possible degradation products.  Figure 12 represents an 
agarose gel showing bacterial DNA used in this study. As can be seen in figure 12, all the 
bacterial DNA preparations were intact and did not show any degradation that would 
interfere with our experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 46
 
 
 
      Ladder  Aa DNA   Ec DNA  Pg DNA  Ss DNA     
 
 
Figure 12. Agarose gel electrophoresis showing the genomic bacterial DNA  
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D. Production of IL-6 from MG-63 cells in response to 100ng/µl bDNA at different 
time points  
The time experiment was performed to determine the optimal time for the release of 
inflammatory cytokines, specifically IL-6 and IL-8. Bacterial DNA (E.Coli DNA, Pg 
DNA, Ss DNA and E.Coli LPS) treated MG-63 cells were collected at designated time 
points (1hr, 2hr, 4hr, 8hr, 12hr and 24hr) and cytokine production was determined using 
ELISA. The results showing the IL-6 production from MG-63 cells stimulated with bDNA 
and LPS are shown in Figure 13 below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 48
 
 
 
 
Figure 13. Increased IL-6 production was observed in MG-63 cells stimulated by bDNA 
and LPS as early as 8 hour 
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E. Production of IL-6 from MG-63 cells in response to 100ng/µl Pg DNA versus 
100ng/µl Pg LPS at different time points  
To further confirm our previous data, MG-63 cells were stimulated again with Pg 
DNA and also Pg LPS 184 and Pg LPS 381. Pg LPS 184 is a less virulent strain than Pg 
LPS 381. The supernatant was collected at different time points (4hr, 8hr, 12hr, and 24hr). 
IL-6 concentration was determined by ELISA and the results were summarized in Figure 
14. 
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Figure 14. Peak increase of IL-6 shown within 12-24 hours 
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The results in figure 14 show release of IL-6 by osteoblasts once challenged with 
bDNA. Pg LPS 184 shows less release then Pg LPS 381 as expected since Pg LPS 184 is 
less virulent than Pg LPS 381. Since the amount of cytokine release is very close between 
12 hours and 24 hours, 20 hours was the optimal stimulating time selected for the release 
of inflammatory cytokines. This has been also reported by different studies done 
previously in our laboratory (Sahingur et al. 2010). 
 
F. Production of IL-6 from MG-63 cells in response to different concentrations of 
bacterial DNA 
The bacterial DNA concentration that was used to stimulate the cells in our 
experiments was determined by stimulating MG-63 cells with different concentration of 
DNA (100µg/ml, 200µg/µl, and 400µg/µl) as shown below in Figure 15. 
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Figure 15. Consistent with the previous reports (Takeshita et al., 1999; Nonnenmacher et 
al. 2003; Dalpke et al. 2006; Sahingur et al. 2010), we also determined 100µg/ml bDNA as 
the optimal stimulating concentration and therefore used this concentration in our assays. 
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G. IL-6 production from MG-63 cells in response to bDNA 
Recent studies from our laboratory indicated that human monocytes (THP-1 cells) 
can produce the key inflammatory cytokine IL-6 following exposure to periodontal 
bacterial DNA (Sahingur et al. 2010). To determine whether osteoblasts produce IL-6 in 
response to bacterial DNA, we have used the osteoblast cell line MG-63 and stimulated 
them with 100µg/ml of the following bacterial DNA (Ss DNA, Aa DNA, Pg DNA, and 
E.coli DNA). E.Coli LPS (1ng/ml) and E.coli DNA served as positive controls while Ss 
DNA served as a non pathogenic oral bacterial control. The cell culture supernatants were 
collected after 20 hours and the IL-6 levels were determined using ELISA. Figure 16 
summarizes IL-6 levels produced by MG-63 cells stimulated with various bacterial DNA. 
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Figure 16.The level of the inflammatory cytokine Interleukin-6 was increased significantly 
in MG-63 cells treated with E.coli DNA and E.coli LPS compared with unstimulated cells. 
On the other hand, even though Ss DNA, Aa DNA and Pg DNA induce IL-6 production 
from MG-63 cells compared to unstimulated cells, the results did not reach significance.  
* (p<0.05)  
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 55
H. IL-6 production from MG-63 cells in response to heat killed whole bacteria 
In addition to bDNA, The MG-63 cells were also stimulated with heat killed 
 whole bacteria. Figure 17 shows the release of IL-6 from MG-63 cells treated with 
different heat killed whole bacteria and bacterial DNA.  
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Figure 17.The results showed a significant release of IL-6 when the osteoblasts are 
stimulated with E.coli DNA and E.coli LPS compared to unstimulated osteoblasts. 
Stimulation with heat killed whole bacteria also induced significant IL-6 release in MG-63 
cells. Again, although periodontal bacterial DNA (Pg DNA and Aa DNA induced IL-6 
production from MG-63 cells, the results were not significant compared to unstimulated 
control cells.  (* p<0.05) 
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I. Effect of chloroquine treatment on IL-6 production from MG-63 cells stimulated 
with bDNA 
To identify the involvement of TLR9 signaling in periodontal bacterial DNA initiated 
IL-6 production in human osteoblasts, MG-63 cells were treated with chloroquine prior to 
bDNA stimulations. Chloroquine, a non-specific TLR9 signaling inhibitor, is known to 
inhibit immune stimulation by bacterial DNA. The inhibition of TLR9 occurs at 
endosomes where chloroquine was shown to block CpG and TLR9 interaction by altering 
endosomal acidification. Figure 18 shows the effect of bacterial DNA on the osteoblasts in 
the presence of chloroquine. 
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Figure 18. Chloroquine treatment had no significant effect on IL-6 production in MG-63 
cells stimulated with bacterial DNA. Surprisingly, the chloroquine treatment slightly 
increased IL-6 levels in cells stimulated with E.coli DNA, but the difference was not 
statistically significant. 
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J. Effect of chloroquine treatment on IL-6 production MG-63 cells stimulated with 
heat killed whole bacteria 
MG-63 cells were stimulated with heat killed whole bacteria in the presence of 
chloroquine and the results are shown in Figure 19. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 60
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19. Chloroquine treatment of MG-63 cells slightly increased the release of IL-6 
when compared with osteoblasts not treated with chloroquine, but the results were not 
statistically significant.  
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K. IL-8 production from MG-63 cells in response to bDNA  
Interleukin IL-8 is a chemokine produced by a variety of tissue and blood cells, and 
is a potent inducer of neutrophil chemotaxis and activation (Waugh &Wilson, 2008). 
Aberrant and persistent production of IL-8 has been demonstrated in various inflammatory 
diseases, including periodontal disease (Yang et al. 2003). To date the interactions of 
bacteria and human osteoblasts are under extensive investigation. The objective of this 
experiment was to investigate the IL-8 production by human osteoblastic cells stimulated 
with bacterial DNA including Ss DNA, Aa DNA, Pg DNA, E.coli DNA and E.coli LPS. 
The IL-8 levels as measured in cell culture supernatants by ELISA are summarized in 
Figure 20. 
 
 
 
 
 
 
 
 
 
 
 
 
 62
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20. The level of the inflammatory chemokine Interleukin-8 was increased 
significantly in MG-63 cells treated with E.coli DNA and E.coli LPS compared with un-
stimulated cells. Ss DNA, Aa DNA and Pg DNA show some release compared with un-
stimulated cells but the results did not reach significance. (*p<0.05) 
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L. IL-8 production from MG-63 cells in response to heat killed whole bacteria 
MG-63 cells were also challenged with heat killed whole bacteria in comparison with 
bacterial DNA. IL-8 production was assessed in cell culture supernatants using ELISA and 
the results are summarized in Figure 21.  
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Figure 21. IL-8 production was significantly increased in response to E.coli DNA and 
E.coli LPS, although heat killed whole bacteria also induced increased cytokine production 
from MG-63 cells the results were not significant. 
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M. Effect of chloroquine treatment on IL-8 production from MG-63 cells stimulated 
with bacterial DNA 
MG-63 cells were treated with chloroquine (10µg/ml) for two hours before DNA 
stimulation. As mentioned previously, chloroquine is an antimalarial agent and widely 
used to block TLR9 signaling by affecting endosomal acidification (El Kebir et al., 2009). 
IL-8 levels were determined in culture supernatants using ELISA (eBiosciences) following 
the manufacturer’s instructions and the results are displayed in figure 22 shown below.  
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Figure 22. Chloroquine treatment of MG-63 cells slightly decreased cytokine production 
in osteoblast when challenged with all bacterial DNA but E.coli DNA. Increased release of 
IL-8 in MG-63 cells was seen in response to E.coli DNA, but the results were not 
significant. 
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N. Effect of chloroquine treatment on IL-8 production from MG-63 cells stimulated 
with heat killed whole bacteria 
MG-63 cells were again stimulated with heat killed whole bacteria but in the 
presence of chloroquine. The results are show in figure 23 below. 
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Figure 23. Chloroquine treatment of MG-63 cells prior to bacterial stimulations resulted 
with increased IL-8 production compared to the cells not treated with chloroquine, but the 
results were not significant. However, compared to un-stimulated control cells, the 
chloroquine treatment resulted in significantly increased IL-8 production in response to 
A.actinomycetemcomitans and S. sanguinis. (* p<0.05) 
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Discussion 
 
Impaired bone homeostasis that results in periodontal bone destruction is commonly 
attributed to chronic inflammation that is initiated by multiple periodontal pathogens.  The 
mechanisms responsible for such clinical outcomes are still under extensive investigation 
(Nair et al. 1996; Liu et al. 2009). The generation of proinflammatory cytokines and 
chemokines is thought to be pivotal in the recruitment and activation of infiltrating 
immune cells. It is also pivotal in the net balance between bone resorption and bone 
formation (Madianos et al. 2005). Periodontal pathogens possess several virulence factors 
that have the ability to trigger inflammatory responses and one of the newly emerging 
periodontal PAMPs, include bacterial DNA. Our studies as well as studies conducted by 
other researchers point out a possible role of bDNA-initiated immune responses in 
periodontal disease pathogenesis (Takeshita et al. 1999; Nonnenmacher et al. 2003; 
Sahingur et al. 2010). Considering the multibacterial etiology of periodontal disease and 
the presence of several bacteria in the oral environment, it is plausible to think that the oral 
tissues represent an environment where bacterial DNA can be abundant and contribute to 
the inflammatory responses.  
Periodontal diseases are unique not only because of their multibacterial etiology but 
also involvement of different cell types and immune responses in different stages of the 
disease.  Previous studies conducted in our laboratory (Sahingur et al, 2010) demonstrated 
increased production of key inflammatory cytokines, IL-1β, IL-6 and TNF-α, in response 
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to periodontal pathogenic DNA in human monocytes. While it is likely that infiltrating 
immune cells, such as monocytes/macrophages, are an important source of these 
inflammatory mediators, there are other cell types that are exposed to these pathogenic 
bacteria and their PAMPs. Osteoblasts are one of these cells that come into play at the 
bone-bacteria interface of periodontal inflammation. Therefore in this study, we seek to 
determine whether periodontal bacterial DNA triggers the production of two key 
inflammatory cytokines, IL-6 and IL-8, in human osteoblastic cells (MG-63). Here, we 
showed the production of both IL-6 and IL-8 in osteoblasts (MG-63 cells) infected with 
periodontal bDNA and whole periodontal bacteria using ELISA. To our knowledge, this is 
the first study that investigated the effect of periodontal bacterial DNA and whole 
periodontal bacteria in inflammatory cytokine production from these cell lines. 
Osteoblasts stimulated by bacterial DNA (Aa DNA, Ss DNA and Pg DNA) released 
IL-6 and IL-8 cytokines but not in amounts significantly different from unstimulated 
osteoblasts (Figures. 16 & 20).  However, E.coli DNA and E.coli LPS -  which were used 
as positive controls triggered the release of IL-6 and IL-8 significantly more, due to their 
inherent virulence (Figures. 16 & 20) (p<0.05). Osteoblasts stimulated by heat killed whole 
bacteria also showed a significantly higher release of cytokines (Figures. 17 & 21) 
(p<0.05). This finding was expected since whole bacteria possess several virulence factors. 
Thus, we would expect these different PAMPs to take different routes by binding to their 
specific receptors, together releasing inflammatory cytokines. In our case, E.coli DNA and 
E.coli LPS triggered osteoblasts to produce more IL-6 and IL-8 than heat killed whole 
bacteria. It is possible that it might take longer for the whole bacterial cell to generate 
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immune responses and therefore further experiments can be planned stimulating MG-63 
cells with whole bacteria for longer periods. Also it is possible that heat killed bacteria 
may not  possess the same abilities as live bacteria which again may warrant further 
investigations using live bacteria to determine the differences.  
TLR9 is considered to be the major receptor that is involved in foreign DNA initiated 
immune responses in several cell types including osteoblasts. However, previous studies 
that investigated TLR9-DNA interactions solely tested the effect of synthetic 
oligonucleotides that are known to mimic bDNA (Zou et al. 2003; Amcheslavsky et al. 
2004; Amcheslavsky et al. 2005). Here we employed whole bacterial genomic DNA to 
assess cytokine production in MG-63 cells that better represents physiological responses. 
One of the drawbacks of using genomic DNA is the possibility of contaminating proteins 
during purification processes, specifically LPS contamination in gram negative bacterial 
cells. We employed several procedures which are described in methods section to obtain 
pure bDNA which is free of any contaminants and we are confident that our DNA 
preparations were pure (Table 5).   
To further investigate the role of TLR9 in periodontal bDNA-induced cytokine 
production in human osteoblastic cells, cells were treated with chloroquine prior to 
stimulations. Our results showed that inhibition of TLR9 signaling by chloroquine resulted 
in slightly decreased IL-8 production (Fig. 22) and slightly increased IL-6 production 
(Figs. 18 & 19) from human osteoblasts. Although, none of the differences were 
statistically significant, it might be speculated that different receptors and signaling 
pathways are involved in triggering IL-6 and IL-8 production in response to periodontal 
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bacterial DNA from MG-63 cells.  It is also important to note that chloroquine exerts its 
effect as a non-specific inhibitor of TLR9 signaling by affecting endosomal acidification. It 
is possible that TLR9 signaling inhibition was not completely inhibited by choloroquine 
which again warrants further investigations creating cells in which TLR9 was knocked 
down using transfections. 
 As mentioned in the Introduction section, there are other cytosolic DNA sensors 
such as DNA –dependent activator of interferon-regulatory factors (DAI) and absent in 
melanoma-2 (AIM-2) for inflammasome (Takaoke et al. 2007; Muruve et al. 2008; Burck, 
Stummer et al. 2009; Fernandes, Alnemri et al. 2009; Hornung et al. 2009; Roberts et al. 
2009) that may play a role in bDNA- induced immune responses in osteoblastic cells. So 
far there are no studies that investigated the expression of these receptors in osteoblastic 
cells, but it can be speculated that inhibition of TLR9 signaling by chloroquine would 
create an environment for other DNA receptors and signaling pathways to be more 
effective resulting in increased production of the inflammatory mediators.  An increase in 
cytokines release was also seen when osteoblasts were stimulated with heat killed whole 
bacteria in the presence of chloroquine which may again be as a result of other signaling 
pathways being more operant when TLR9 signaling is inhibited. 
Although we demonstrated increased IL-6 and IL-8 production in response to 
periodontal bacterial DNA from MG-63 cells, the differences were not significant 
compared to unstimulated controls. IL-6 and IL-8 are undoubtfully important in 
periodontal pathology, however, there are also other inflammatory mediators that can 
contribute to tissue destruction such as RANKL (Zou et al. 2003), IL-12 (Hiroyoki et al. 
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2005), TNF-α (Graves and Cochran 2003; Hiroyoki et al. 2005) and IL-1 ( Graves and 
Cochran 2003). The production of these inflammatory mediators by bDNA stimulated- 
osteoblasts may contribute to the development of progressive inflammatory damage and 
aberrant bone remodeling associated with the pathology of periodontal disease. Treatment 
of MG-63 cells with chloroquine prior to bDNA stimulation resulted in decreased IL-8 and 
increased IL-6 production. These results indicate that different signaling pathways might 
be involved in bDNA-initiated cytokine production in osteoblasts for different 
inflammatory mediators. Hence, although our results were not significant for IL-6 and IL-
8, it is safe to suggest that human osteoblasts can respond to periodontal bDNA. Thus, 
further studies are needed that will assess the production of other inflammatory mediators 
in response to periodontal bDNA to fully elucidate the role of bDNA-initiated immune 
responses in periodontal disease pathology. 
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